Symmetry Partners LLC Decreases Position in Danaher Co. (NYSE:DHR)

Symmetry Partners LLC reduced its stake in Danaher Co. (NYSE:DHRFree Report) by 90.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 735 shares of the conglomerate’s stock after selling 6,671 shares during the period. Symmetry Partners LLC’s holdings in Danaher were worth $204,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. CarsonAllaria Wealth Management Ltd. purchased a new stake in shares of Danaher in the 2nd quarter valued at about $25,000. nVerses Capital LLC purchased a new stake in Danaher in the second quarter valued at approximately $25,000. MFA Wealth Advisors LLC acquired a new stake in shares of Danaher in the second quarter valued at approximately $51,000. Financial Connections Group Inc. purchased a new position in shares of Danaher during the second quarter worth approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new position in shares of Danaher in the 1st quarter valued at $55,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on DHR. Stifel Nicolaus increased their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Barclays dropped their price target on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Leerink Partners increased their price objective on Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. The Goldman Sachs Group lifted their target price on shares of Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Finally, Wells Fargo & Company began coverage on shares of Danaher in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price objective for the company. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $287.16.

Get Our Latest Analysis on DHR

Danaher Trading Up 0.9 %

Shares of Danaher stock traded up $2.10 during trading hours on Friday, reaching $247.76. 2,638,494 shares of the company’s stock were exchanged, compared to its average volume of 2,752,238. The firm has a market capitalization of $178.95 billion, a price-to-earnings ratio of 47.29, a price-to-earnings-growth ratio of 4.45 and a beta of 0.83. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 52-week low of $190.95 and a 52-week high of $281.70. The company has a fifty day moving average of $266.95 and a 200-day moving average of $260.37.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same period last year, the company earned $2.02 EPS. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. Sell-side analysts forecast that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is 20.61%.

Insiders Place Their Bets

In related news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is currently owned by insiders.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.